Related Experiment Video
Updated: Feb 22, 2026
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
Survival results in five malignant neoplasms separated by a decade at Institut Català d'Oncologia, Spain
José Ramón Germá-Lluch1, Lourdes Petriz1, Pau Lopez1
1Oficina de Resultados Oncológicos (ORO), Dirección de Estrategia Clínica, Investigación y Resultados Clínicos, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, España.
Background And Objective:
Five years' data relative survival (RS) is presented in 3 solid tumours: breast, colorectal (CRC) and lung and 2 haematologic neoplasms: large B cell lymphoma (NHL-B) and multiple myeloma (MM) treated at Institut Català d'Oncologia between 2010-2011 in comparison with the results obtained in a historical special cohort from 1998-1999.
Material And Methods:
A database was created in a common safe and accessible repository. We have introduced more than 5,000 medical records. To analyse the results the statistical package R® was used for RS.
Results:
The overall RS at 5 years for 2010-2011 was: CRC 67%, breast 93.6%, lung 28%, NHL-B 68% and MM 62%, while for 1998-1999 is was: CRC 61.8%, breast 88.8%, lung 23.1%, NHL-B 67.7%, and MM 43.4%.
Conclusions:
Comparative results have shown a 5% overall improvement in RS for the 3 solid tumours, a significant increase in MM and a stabilisation in the NHL-B.